{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T01:17:05Z","timestamp":1793150225766,"version":"4.5.0"},"reference-count":53,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T00:00:00Z","timestamp":1732233600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Epstein-Barr virus (EBV)+ and EBV- primary CNS lymphomas (PCNSL) carry distinct mutational landscapes, but their transcriptional and epigenetic profiles have not been integrated and compared. This precludes further insights into pathobiology and molecular differences, relevant for classification and targeted therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Twenty-three EBV- and 15 EBV+ PCNSL, histologically classified as diffuse large B-cell lymphomas, were subjected to RNA-sequencing and EPIC methylation arrays. Unsupervised clustering analyses were performed. Differentially expressed and differentially methylated genes were identified and integrated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Two distinct transcriptional clusters were found, which separated EBV- and EBV+ PCNSL (P\u2005&amp;lt;\u2005.0001). The EBV+ transcriptional signature contained genes (GPR15, FCER2\/CD23, SLAMF1\/CD150) closely regulated by EBV oncogenes in B cells. Pathway enrichment analysis uncovered enhanced B-cell receptor (BCR) and WNT\/beta-catenin signaling in EBV- lymphomas, whereas Interleukin-10, NOTCH, and viral life cycle pathways were upregulated in EBV+ PCNSL. Correspondingly, BCR-associated SYK kinase activity was enriched in EBV- tumors while JAK2 was overrepresented in EBV+ PCNSL. Epigenetic profiling revealed reduced global promoter methylation in EBV+ PCNSL. Two methylation clusters were recognized, which separated EBV- and EBV+ PCNSL (P\u2005&amp;lt;\u2005.0001). Epigenetic profiles were distinct from 2,788 other brain tumor and nonmalignant reference samples. Promoter region hypermethylation of CD79B, a BCR subunit critical for sustained proliferation in EBV- disease, highly correlated (R\u2005=\u2005\u22120.7) with its transcriptional downregulation in EBV+ PCNSL.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>EBV+ and EBV- PCNSL harbor distinct transcriptional and epigenetic profiles, corroborating them as distinctive biological subtypes. Uncovered differences provide novel insights into their pathobiology, may guide molecular diagnostics and targeted therapies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/neuonc\/noae251","type":"journal-article","created":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T07:20:54Z","timestamp":1732173654000},"page":"979-992","source":"Crossref","is-referenced-by-count":13,"title":["Distinct epigenetic and transcriptional profiles of Epstein-Barr virus-positive and negative primary CNS lymphomas"],"prefix":"10.1093","volume":"27","author":[{"given":"Ling","family":"Hai","sequence":"first","affiliation":[{"name":"Clinical Cooperation Unit (CCU) Neuro-Oncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK) , Heidelberg ,","place":["Germany"]},{"name":"Department of Neurology, University Hospital Heidelberg, Heidelberg University , Heidelberg ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5067-3009","authenticated-orcid":false,"given":"Dennis","family":"Friedel","sequence":"additional","affiliation":[{"name":"Faculty of Biosciences, Heidelberg University , Heidelberg ,","place":["Germany"]},{"name":"Department of Neuropathology, Heidelberg University Hospital, and Clinical Cooperation Unit (CCU) Neuropathology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK) , Heidelberg ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6394-1999","authenticated-orcid":false,"given":"Felix","family":"Hinz","sequence":"additional","affiliation":[{"name":"Department of Neuropathology, Heidelberg University Hospital, and Clinical Cooperation Unit (CCU) Neuropathology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK) , Heidelberg ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1370-1933","authenticated-orcid":false,"given":"Dirk C","family":"Hoffmann","sequence":"additional","affiliation":[{"name":"Clinical Cooperation Unit (CCU) Neuro-Oncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK) , Heidelberg ,","place":["Germany"]},{"name":"Department of Neurology, University Hospital Heidelberg, Heidelberg University , Heidelberg ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1727-8906","authenticated-orcid":false,"given":"Sofia","family":"Doubrovinskaia","sequence":"additional","affiliation":[{"name":"Department of Neurology, University Hospital Heidelberg, Heidelberg University , Heidelberg ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4985-1231","authenticated-orcid":false,"given":"Hannah","family":"Rohdjess","sequence":"additional","affiliation":[{"name":"Faculty of Biosciences, Heidelberg University , Heidelberg ,","place":["Germany"]},{"name":"Clinical Cooperation Unit (CCU) Neuro-Oncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK) , Heidelberg ,","place":["Germany"]},{"name":"Department of Neurology, University Hospital Heidelberg, Heidelberg University , Heidelberg ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Weidenauer","sequence":"additional","affiliation":[{"name":"Department of Neurology, University Hospital Heidelberg, Heidelberg University , Heidelberg ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evgeniya","family":"Denisova","sequence":"additional","affiliation":[{"name":"Division of Applied Bioinformatics, German Consortium for Translational Cancer Research (DKTK), German Cancer Research Center (DKFZ) , Heidelberg ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg T","family":"Scheffler","sequence":"additional","affiliation":[{"name":"Department of Neurology, Yale School of Medicine , New Haven, Connecticut ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8350-7074","authenticated-orcid":false,"given":"Tobias","family":"Kessler","sequence":"additional","affiliation":[{"name":"Clinical Cooperation Unit (CCU) Neuro-Oncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK) , Heidelberg ,","place":["Germany"]},{"name":"Department of Neurology, University Hospital Heidelberg, Heidelberg University , Heidelberg ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7894-9131","authenticated-orcid":false,"given":"Alexandros","family":"Kourtesakis","sequence":"additional","affiliation":[{"name":"Faculty of Biosciences, Heidelberg University , Heidelberg ,","place":["Germany"]},{"name":"Clinical Cooperation Unit (CCU) Neuro-Oncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK) , Heidelberg ,","place":["Germany"]},{"name":"Department of Neurology, University Hospital Heidelberg, Heidelberg University , Heidelberg ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1915-745X","authenticated-orcid":false,"given":"Christel","family":"Herold-Mende","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University Hospital Heidelberg, Heidelberg University , Heidelberg ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8971-1049","authenticated-orcid":false,"given":"Octavian","family":"Henegariu","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Yale School of Medicine , New Haven, Connecticut ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7755-6793","authenticated-orcid":false,"given":"Joachim M","family":"Baehring","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Yale School of Medicine , New Haven, Connecticut ,","place":["USA"]},{"name":"Department of Neurology, Yale School of Medicine , New Haven, Connecticut ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8291-0136","authenticated-orcid":false,"given":"Jorg","family":"Dietrich","sequence":"additional","affiliation":[{"name":"Department of Neurology, Division of Neuro-Oncology, Massachusetts General Hospital, Harvard Medical School , Boston, Massachusetts ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5940-3101","authenticated-orcid":false,"given":"Benedikt","family":"Brors","sequence":"additional","affiliation":[{"name":"Division of Applied Bioinformatics, German Consortium for Translational Cancer Research (DKTK), German Cancer Research Center (DKFZ) , Heidelberg ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6171-634X","authenticated-orcid":false,"given":"Wolfgang","family":"Wick","sequence":"additional","affiliation":[{"name":"Clinical Cooperation Unit (CCU) Neuro-Oncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK) , Heidelberg ,","place":["Germany"]},{"name":"Department of Neurology, University Hospital Heidelberg, Heidelberg University , Heidelberg ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5441-1962","authenticated-orcid":false,"given":"Felix","family":"Sahm","sequence":"additional","affiliation":[{"name":"Department of Neuropathology, Heidelberg University Hospital, and Clinical Cooperation Unit (CCU) Neuropathology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK) , Heidelberg ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5937-3376","authenticated-orcid":false,"given":"Leon D","family":"Kaulen","sequence":"additional","affiliation":[{"name":"Department of Neurology, Division of Neuro-Oncology, Massachusetts General Hospital, Harvard Medical School , Boston, Massachusetts ,","place":["USA"]},{"name":"Clinical Cooperation Unit (CCU) Neuro-Oncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK) , Heidelberg ,","place":["Germany"]},{"name":"Department of Neurology, University Hospital Heidelberg, Heidelberg University , Heidelberg ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,11,22]]},"reference":[{"issue":"1","key":"2025052712370167500_CIT0001","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/neuonc\/noac196","article-title":"European Association of Neuro-Oncology (EANO) guidelines for treatment of primary central nervous system lymphoma (PCNSL)","volume":"25","author":"Hoang-Xuan","year":"2023","journal-title":"Neuro Oncol."},{"issue":"9","key":"2025052712370167500_CIT0002","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1182\/blood.2020008377","article-title":"Primary central nervous system lymphoma","volume":"140","author":"Schaff","year":"2022","journal-title":"Blood."},{"issue":"12 Suppl 2","key":"2025052712370167500_CIT0003","doi-asserted-by":"crossref","first-page":"iv1","DOI":"10.1093\/neuonc\/noad149","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2016-2020","volume":"25","author":"Ostrom","year":"2023","journal-title":"Neuro Oncol"},{"issue":"12","key":"2025052712370167500_CIT0004","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1136\/jnnp-2020-325759","article-title":"Primary CNS lymphoma after CLIPPERS: a case series","volume":"92","author":"Doubrovinskaia","year":"2021","journal-title":"J Neurol Neurosurg Psychiatry."},{"issue":"1","key":"2025052712370167500_CIT0005","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1093\/neuonc\/now155","article-title":"Long-term survival in AIDS-related primary central nervous system lymphoma","volume":"19","author":"Gupta","year":"2017","journal-title":"Neuro Oncol"},{"issue":"8","key":"2025052712370167500_CIT0006","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1212\/WNL.0000000000004265","article-title":"Long-term AIDS-related PCNSL outcomes with HD-MTX and combined antiretroviral therapy","volume":"89","author":"Moulignier","year":"2017","journal-title":"Neurology."},{"issue":"1","key":"2025052712370167500_CIT0007","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1038\/s41467-022-30050-y","article-title":"The genomic and transcriptional landscape of primary central nervous system lymphoma","volume":"13","author":"Radke","year":"2022","journal-title":"Nat Commun."},{"issue":"2","key":"2025052712370167500_CIT0008","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.annonc.2022.11.002","article-title":"Molecular and clinical diversity in primary central nervous system lymphoma","volume":"34","author":"Hern\u00e1ndez-Verdin","year":"2023","journal-title":"Ann Oncol."},{"issue":"6","key":"2025052712370167500_CIT0009","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s00401-016-1536-2","article-title":"Genomic characterization of primary central nervous system lymphoma","volume":"131","author":"Fukumura","year":"2016","journal-title":"Acta Neuropathol."},{"issue":"17","key":"2025052712370167500_CIT0010","doi-asserted-by":"crossref","first-page":"3986","DOI":"10.1158\/1078-0432.CCR-14-2116","article-title":"Genome-wide analysis uncovers novel recurrent alterations in primary central nervous system lymphomas","volume":"21","author":"Braggio","year":"2015","journal-title":"Clin Cancer Res."},{"issue":"3","key":"2025052712370167500_CIT0011","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/leu.2014.264","article-title":"The mutational pattern of primary lymphoma of the central nervous system determined by whole-exome sequencing","volume":"29","author":"Vater","year":"2015","journal-title":"Leukemia."},{"issue":"2","key":"2025052712370167500_CIT0012","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/bjh.17319","article-title":"Exome sequencing identifies SLIT2 variants in primary CNS lymphoma","volume":"193","author":"Kaulen","year":"2021","journal-title":"Br J Haematol."},{"issue":"3","key":"2025052712370167500_CIT0013","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s00401-023-02613-w","article-title":"Integrated genetic analyses of immunodeficiency-associated Epstein-Barr virus- (EBV) positive primary CNS lymphomas","volume":"146","author":"Kaulen","year":"2023","journal-title":"Acta Neuropathol."},{"issue":"11","key":"2025052712370167500_CIT0014","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1182\/blood.2020008520","article-title":"EBV-associated primary CNS lymphoma occurring after immunosuppression is a distinct immunobiological entity","volume":"137","author":"Gandhi","year":"2021","journal-title":"Blood."},{"issue":"20","key":"2025052712370167500_CIT0015","doi-asserted-by":"crossref","first-page":"3652","DOI":"10.1016\/j.cell.2022.08.026","article-title":"Epstein-Barr virus: biology and clinical disease","volume":"185","author":"Damania","year":"2022","journal-title":"Cell."},{"issue":"1","key":"2025052712370167500_CIT0016","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","article-title":"Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray","volume":"103","author":"Hans","year":"2004","journal-title":"Blood."},{"issue":"11","key":"2025052712370167500_CIT0017","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1111\/ajt.12858","article-title":"A comprehensive analysis of the cellular and EBV-specific microRNAome in primary CNS PTLD identifies different patterns among EBV-associated tumors","volume":"14","author":"Fink","year":"2014","journal-title":"Am J Transplant."},{"issue":"12","key":"2025052712370167500_CIT0018","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"issue":"7697","key":"2025052712370167500_CIT0019","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nature26000","article-title":"DNA methylation-based classification of central nervous system tumours","volume":"555","author":"Capper","year":"2018","journal-title":"Nature."},{"issue":"29","key":"2025052712370167500_CIT0020","doi-asserted-by":"crossref","first-page":"861","DOI":"10.21105\/joss.00861","article-title":"UMAP: Uniform Manifold Approximation and Projection","volume":"3","author":"McInnes","year":"2018","journal-title":"J Open Source Softw."},{"issue":"10","key":"2025052712370167500_CIT0021","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1073\/pnas.84.10.3452","article-title":"Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23","volume":"84","author":"Wang","year":"1987","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"1","key":"2025052712370167500_CIT0022","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/ni0103-19","article-title":"The dual-function CD150 receptor subfamily: the viral attraction","volume":"4","author":"Sidorenko","year":"2003","journal-title":"Nat Immunol."},{"issue":"6","key":"2025052712370167500_CIT0023","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/ng.2653","article-title":"The Genotype-Tissue Expression (GTEx) project","volume":"45","author":"Lonsdale","year":"2013","journal-title":"Nat Genet."},{"issue":"3","key":"2025052712370167500_CIT0024","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/nrc.2017.121","article-title":"Targeting B cell receptor signalling in cancer: preclinical and clinical advances","volume":"18","author":"Burger","year":"2018","journal-title":"Nat Rev Cancer."},{"issue":"May","key":"2025052712370167500_CIT0025","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ebiom.2019.04.045","article-title":"Pan-cancer genomic analysis links 3\u2019UTR DNA methylation with increased gene expression in T cells","volume":"43","author":"McGuire","year":"2019","journal-title":"EBioMedicine"},{"issue":"6769","key":"2025052712370167500_CIT0026","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling","volume":"403","author":"Alizadeh","year":"2000","journal-title":"Nature."},{"issue":"8","key":"2025052712370167500_CIT0027","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1158\/2159-8290.CD-20-0242","article-title":"Surface proteomics reveals CD72 as a target for in vitro\u2013evolved nanobody-based CAR-T cells in KMT2A\/MLL1-rearranged B-ALL","volume":"11","author":"Nix","year":"2021","journal-title":"Cancer Discov"},{"issue":"10","key":"2025052712370167500_CIT0028","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1182\/blood.2024023832","article-title":"Rapid tumor DNA analysis of cerebrospinal fluid accelerates treatment of central nervous system lymphoma","volume":"144","author":"Gupta","year":"2024","journal-title":"Blood."},{"issue":"9","key":"2025052712370167500_CIT0029","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1200\/JCO.22.00826","article-title":"Circulating tumor DNA profiling for detection, risk stratification, and classification of brain lymphomas","volume":"41","author":"Mutter","year":"2023","journal-title":"J Clin Oncol."},{"issue":"1","key":"2025052712370167500_CIT0030","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41579-022-00770-5","article-title":"Epstein\u2013Barr virus and multiple sclerosis","volume":"21","author":"Soldan","year":"2023","journal-title":"Nat Rev Microbiol."},{"issue":"1","key":"2025052712370167500_CIT0031","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2353\/ajpath.2008.070845","article-title":"Expression of the Epstein-Barr virus-encoded Epstein-Barr virus nuclear antigen 1 in Hodgkin\u2019s lymphoma cells mediates up-regulation of CCL20 and the migration of regulatory T cells","volume":"173","author":"Baumforth","year":"2008","journal-title":"Am J Pathol."},{"issue":"7332","key":"2025052712370167500_CIT0032","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nature09671","article-title":"Oncogenically active MYD88 mutations in human lymphoma","volume":"470","author":"Ngo","year":"2011","journal-title":"Nature."},{"issue":"1","key":"2025052712370167500_CIT0033","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1038\/s41598-017-02792-z","article-title":"De novo non-synonymous TBL1XR1 mutation alters Wnt signaling activity","volume":"7","author":"Nishi","year":"2017","journal-title":"Sci Rep."},{"issue":"8","key":"2025052712370167500_CIT0034","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1182\/blood-2005-07-2730","article-title":"NF-kappaB is essential for the progression of KSHV- and EBV-infected lymphomas in vivo","volume":"107","author":"Keller","year":"2006","journal-title":"Blood."},{"issue":"1","key":"2025052712370167500_CIT0035","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41392-024-01757-9","article-title":"NF-\u03baB in biology and targeted therapy: new insights and translational implications","volume":"9","author":"Guo","year":"2024","journal-title":"Signal Transduct Target Ther."},{"issue":"2","key":"2025052712370167500_CIT0036","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1101\/gr.157743.113","article-title":"Large-scale hypomethylated blocks associated with Epstein-Barr virus-induced B-cell immortalization","volume":"24","author":"Hansen","year":"2014","journal-title":"Genome Res."},{"issue":"2","key":"2025052712370167500_CIT0037","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00401-016-1664-8","article-title":"Genome-wide DNA methylation profiling identifies primary central nervous system lymphoma as a distinct entity different from systemic diffuse large B-cell lymphoma","volume":"133","author":"Nakamura","year":"2017","journal-title":"Acta Neuropathol."},{"issue":"2","key":"2025052712370167500_CIT0038","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1182\/blood-2010-04-279539","article-title":"Aberrant global methylation patterns affect the molecular pathogenesis and prognosis of multiple myeloma","volume":"117","author":"Walker","year":"2011","journal-title":"Blood."},{"issue":"22","key":"2025052712370167500_CIT0039","doi-asserted-by":"crossref","first-page":"5870","DOI":"10.1182\/blood-2010-09-310318","article-title":"CD300a is expressed on human B cells, modulates BCR-mediated signaling, and its expression is down-regulated in HIV infection","volume":"117","author":"Silva","year":"2011","journal-title":"Blood."},{"issue":"5","key":"2025052712370167500_CIT0040","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1111\/ajt.12196","article-title":"Gene expression profiling reveals clear differences between EBV-positive and EBV-negative posttransplant lymphoproliferative disorders","volume":"13","author":"Morscio","year":"2013","journal-title":"Am J Transplant."},{"issue":"7","key":"2025052712370167500_CIT0041","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1158\/1078-0432.CCR-14-1216","article-title":"Global promoter methylation analysis reveals novel candidate tumor suppressor genes in natural killer cell lymphoma","volume":"21","author":"K\u00fc\u00e7\u00fck","year":"2015","journal-title":"Clin Cancer Res."},{"issue":"23","key":"2025052712370167500_CIT0042","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1042\/BCJ20220417","article-title":"Regulation of B cell receptor signalling by Epstein-Barr virus nuclear antigens","volume":"479","author":"Khasnis","year":"2022","journal-title":"Biochem J."},{"issue":"10","key":"2025052712370167500_CIT0043","doi-asserted-by":"crossref","first-page":"3715","DOI":"10.1182\/blood-2007-05-090142","article-title":"Epstein-Barr virus latent membrane protein 2A is a B-cell receptor mimic and essential for B-cell survival","volume":"110","author":"Mancao","year":"2007","journal-title":"Blood."},{"issue":"1","key":"2025052712370167500_CIT0044","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1182\/blood-2008-06-160937","article-title":"Epstein-Barr virus latent membrane protein 2A exploits Notch1 to alter B-cell identity in vivo","volume":"113","author":"Anderson","year":"2009","journal-title":"Blood."},{"issue":"4","key":"2025052712370167500_CIT0045","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1182\/blood.2024023847","article-title":"Ibrutinib as part of risk-stratified treatment for post-transplant lymphoproliferative disorder: the phase 2 TIDaL trial","volume":"144","author":"Chaganti","year":"2024","journal-title":"Blood."},{"issue":"3","key":"2025052712370167500_CIT0046","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S1470-2045(23)00649-6","article-title":"Tabelecleucel for allogeneic haematopoietic stem-cell or solid organ transplant recipients with Epstein-Barr virus-positive post-transplant lymphoproliferative disease after failure of rituximab or rituximab and chemotherapy (ALLELE): a phase 3, multicentre, open-label trial","volume":"25","author":"Mahadeo","year":"2024","journal-title":"Lancet Oncol."},{"issue":"9","key":"2025052712370167500_CIT0047","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1056\/NEJMoa1110557","article-title":"A double-blind, placebo-controlled trial of ruxolitinib for myelofibrosis","volume":"366","author":"Verstovsek","year":"2012","journal-title":"N Engl J Med."},{"issue":"23","key":"2025052712370167500_CIT0048","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1182\/blood-2017-01-764209","article-title":"PD-1 blockade with nivolumab in relapsed\/refractory primary central nervous system and testicular lymphoma","volume":"129","author":"Nayak","year":"2017","journal-title":"Blood."},{"issue":"1","key":"2025052712370167500_CIT0049","first-page":"vdac051","article-title":"Intraventricular immune checkpoint inhibition with nivolumab in relapsed primary central nervous system lymphoma","volume":"4","author":"Kaulen","year":"2022","journal-title":"Neurooncol Adv."},{"issue":"6702","key":"2025052712370167500_CIT0050","doi-asserted-by":"crossref","first-page":"eade8520","DOI":"10.1126\/science.ade8520","article-title":"JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma","volume":"384","author":"Zak","year":"2024","journal-title":"Science."},{"issue":"6","key":"2025052712370167500_CIT0051","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/j.cell.2016.11.022","article-title":"Tumor interferon signaling regulates a multigenic resistance program to immune checkpoint blockade","volume":"167","author":"Benci","year":"2016","journal-title":"Cell."},{"issue":"9","key":"2025052712370167500_CIT0052","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1158\/2159-8290.CD-17-0613","article-title":"Ibrutinib unmasks critical role of bruton tyrosine kinase in primary CNS lymphoma","volume":"7","author":"Grommes","year":"2017","journal-title":"Cancer Discov"},{"issue":"4","key":"2025052712370167500_CIT0053","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1093\/annonc\/mdz032","article-title":"Lenalidomide in combination with intravenous rituximab (REVRI) in relapsed\/refractory primary CNS lymphoma or primary intraocular lymphoma: a multicenter prospective \u201cproof of concept\u201d phase II study of the French Oculo-Cerebral lymphoma (LOC) Network and the Lymphoma Study Association (LYSA)\u2020","volume":"30","author":"Ghesquieres","year":"2019","journal-title":"Ann Oncol."}],"container-title":["Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/advance-article-pdf\/doi\/10.1093\/neuonc\/noae251\/60786185\/noae251.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/27\/4\/979\/60786185\/noae251.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/27\/4\/979\/60786185\/noae251.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T12:37:16Z","timestamp":1748349436000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article\/27\/4\/979\/7906908"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,22]]},"references-count":53,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,11,22]]},"published-print":{"date-parts":[[2025,5,15]]}},"URL":"https:\/\/doi.org\/10.1093\/neuonc\/noae251","relation":{},"ISSN":["1522-8517","1523-5866"],"issn-type":[{"value":"1522-8517","type":"print"},{"value":"1523-5866","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,4]]},"published":{"date-parts":[[2024,11,22]]}}}